XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-12-18: Form 6-K; Period of report 2019-12-18; Description REPORT OF FOREIGN PRIVATE ISSUER; Document f6k121719_xtlbiopharma.htm.
- 2019-11-27: Form 6-K; Period of report 2019-11-27; Description FORM 6-K; Document f6k112719_xtlbiopharma.htm.
- 2019-10-31: Form 6-K; Period of report 2019-10-31; Description REPORT OF FOREIGN PRIVATE ISSUER; Document f6k103119_xtlbiopharma.htm.
- 2019-09-04: Form 6-K; Period of report 2019-09-04; Description REPORT OF FOREIGN PRIVATE ISSUER; Document f6k090319_xtlbiopharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2019-12-18 | 6-K | 2019-12-18 | REPORT OF FOREIGN PRIVATE ISSUER | f6k121719_xtlbiopharma.htm |
| 2019-11-27 | 6-K | 2019-11-27 | FORM 6-K | f6k112719_xtlbiopharma.htm |
| 2019-10-31 | 6-K | 2019-10-31 | REPORT OF FOREIGN PRIVATE ISSUER | f6k103119_xtlbiopharma.htm |
| 2019-09-04 | 6-K | 2019-09-04 | REPORT OF FOREIGN PRIVATE ISSUER | f6k090319_xtlbiopharma.htm |
| 2019-05-30 | 6-K | 2019-05-30 | CURRENT REPORT OF FOREIGN ISSUER | f6k053019_xtlbiopharma.htm |